resiquimod has been researched along with ovalbumin in 19 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (ovalbumin) | Trials (ovalbumin) | Recent Studies (post-2010) (ovalbumin) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 19,565 | 63 | 5,664 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Imbertson, LM; Stanczak, TL; Tomai, MA; Tygrett, LT; Waldschmidt, TJ | 1 |
| Gibson, SJ; Lindh, JM; Pederson, LK; Reiter, MJ; Smith, MH; Smith, RM; Tomai, MA; Vasilakos, JP | 1 |
| Brett, SJ; Daly, MG; Thomsen, LL; Tite, JP; Topley, P | 1 |
| Ahrens, B; Hamelmann, E; Joachim, RA; Kallinich, T; Quarcoo, D; Stock, P; Weixler, S | 1 |
| Bosio, C; Dow, S; Guth, A; Izzo, A; Jordan, M; Kedl, R; Sellins, K; Zaks, K | 1 |
| Alber, G; Bauer, S; Garn, H; Renz, H; Sel, S; Wegmann, M | 1 |
| Camateros, P; Henri, J; Hudson, TJ; Kanagaratham, C; Radzioch, D; Sladek, R | 1 |
| Aumeunier, A; Bardel, E; Bourgeois, E; Dy, M; Grela, F; Herbelin, A; Leite-de-Moraes, M; Schneider, E; Thieblemont, N; Van, LP; Vanoirbeek, J | 1 |
| Bardel, E; Dy, M; Gregoire, S; Schneider, E; Thieblemont, N; Van, LP; Vanoirbeek, J | 1 |
| Dong, H; Leclerc, C; Majlessi, L; Olivier, A; Sainz-Perez, A; Sparwasser, T | 1 |
| Becker, M; Böhm, L; Buhl, R; Dehzad, N; Martin, H; Reuter, S; Stassen, M; Taube, C | 1 |
| Anz, D; Bohn, B; Bourquin, C; Endres, S; Heidegger, S; Hotz, C; Kirchner, SK; Rüssmann, H; Sandholzer, N; Stecher, B; Stephan, N; Suhartha, N | 1 |
| Agace, WW; Bain, CC; Cerovic, V; Davison, ES; Houston, SA; Joeris, T; Kroczek, RA; Milling, SW; Mowat, AM; Scott, CL; Utriainen, L; Westlund, J; Yrlid, U | 1 |
| Cascalho, M; Clark, KL; Kahlenberg, JM; Morse, MD | 1 |
| Buffa, V; Doyle-Meyers, L; Fischetti, L; King, DF; Klein, K; Shattock, RJ; Siddiqui, A; Tregoning, JS; Veazey, RS | 1 |
| Qiu, F; Shen, Y; Tang, H; Zeng, M | 1 |
| Chen, B; Fan, H; Li, M; Qin, T; Qu, S; Wei, J; Ye, L; Zhang, S | 1 |
| Bamberger, D; Bros, M; Grabbe, S; Jiang, S; Landfester, K; Li, M; Mailänder, V; Paßlick, D; Piradashvili, K; R Wich, P; Strand, D | 1 |
| Ainslie, KM; Bachelder, EM; Batty, CJ; Genito, CJ; Moore, KM; Stiepel, RT | 1 |
19 other study(ies) available for resiquimod and ovalbumin
| Article | Year |
|---|---|
The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antibody Specificity; Antigens, CD; B-Lymphocytes; B7-2 Antigen; Cells, Cultured; Guanosine; Humans; Imidazoles; Imiquimod; Immunoglobulin Class Switching; Immunoglobulin E; Immunoglobulin G; Lipopolysaccharides; Lymphocyte Activation; Membrane Glycoproteins; Mice; Mice, Inbred Strains; Ovalbumin; Spleen | 2000 |
Adjuvant activities of immune response modifier R-848: comparison with CpG ODN.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Cell Separation; Cytokines; Female; Imidazoles; Immunization, Secondary; Immunoglobulin E; Immunoglobulin G; Interferon-gamma; Mice; Mice, Inbred BALB C; Oligodeoxyribonucleotides; Ovalbumin; Spleen; Th1 Cells; Th2 Cells; Vaccination | 2000 |
Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Biolistics; CD11 Antigens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Imidazoles; Imiquimod; Immunization; Immunotherapy; Injections, Subcutaneous; Interferon-gamma; Lymph Nodes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microspheres; Ovalbumin; Plasmids; Th1 Cells; Vaccines, DNA | 2004 |
Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice.
Topics: Allergens; Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Female; Imidazoles; Immunologic Factors; Interferon-gamma; Interleukin-12; Interleukin-4; Interleukin-5; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Ovalbumin; Th2 Cells | 2004 |
Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes.
Topics: Adaptor Proteins, Signal Transducing; Adjuvants, Immunologic; Animals; Cancer Vaccines; Cations; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cross-Priming; Female; Imidazoles; Lipopolysaccharides; Liposomes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Mycobacterium tuberculosis; Myeloid Differentiation Factor 88; Oligodeoxyribonucleotides; Ovalbumin; Poly I-C; Signal Transduction; Toll-Like Receptor 3; Toll-Like Receptor 9; Zymosan | 2006 |
Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10.
Topics: Animals; Antibodies; Antiviral Agents; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cytokines; Female; Imidazoles; Immunoglobulin E; Immunoglobulin G; Immunosuppression Therapy; Interleukin-10; Interleukin-12; Interleukin-12 Subunit p35; Ligands; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Ovalbumin; Poly I-C; Toll-Like Receptor 3; Toll-Like Receptor 7 | 2007 |
Modulation of the allergic asthma transcriptome following resiquimod treatment.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; CD8 Antigens; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation; Imidazoles; Killer Cells, Natural; Mice; Mice, Inbred C57BL; Mice, Knockout; Ovalbumin; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma.
Topics: Adoptive Transfer; Animals; Anti-Allergic Agents; Asthma; Drug Delivery Systems; Imidazoles; Inflammation Mediators; Interferon-gamma; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Natural Killer T-Cells; Ovalbumin; Toll-Like Receptor 7 | 2011 |
Treatment with the TLR7 agonist R848 induces regulatory T-cell-mediated suppression of established asthma symptoms.
Topics: Animals; Asthma; Disease Models, Animal; Imidazoles; Interleukin-10; Lung; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Ovalbumin; T-Lymphocytes, Regulatory; Toll-Like Receptor 7; Transforming Growth Factor beta | 2011 |
The adjuvant effect of TLR agonists on CD4(+) effector T cells is under the indirect control of regulatory T cells.
Topics: Adjuvants, Immunologic; Amino Acid Sequence; Animals; CD4-Positive T-Lymphocytes; Female; Flow Cytometry; Forkhead Transcription Factors; Gene Expression Profiling; Green Fluorescent Proteins; Imidazoles; Lipopolysaccharides; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Molecular Sequence Data; Oligodeoxyribonucleotides; Ovalbumin; Peptide Fragments; Poly I-C; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes, Regulatory; Toll-Like Receptors; Zymosan | 2011 |
TLR3 but not TLR7/8 ligand induces allergic sensitization to inhaled allergen.
Topics: Administration, Inhalation; Allergens; Animals; Dendritic Cells; Disease Models, Animal; Hypersensitivity; Imidazoles; Ligands; Lipopolysaccharides; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Ovalbumin; Poly I-C; Toll-Like Receptor 3; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2012 |
TLR activation excludes circulating naive CD8+ T cells from gut-associated lymphoid organs in mice.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Movement; Cell Proliferation; Dendritic Cells; Down-Regulation; Female; Imidazoles; Integrins; Interleukin-12 Subunit p40; Interleukin-6; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Ovalbumin; Salmonella Infections; Salmonella typhimurium; Signal Transduction; T-Lymphocyte Subsets; Toll-Like Receptors | 2013 |
Lymph-borne CD8α+ dendritic cells are uniquely able to cross-prime CD8+ T cells with antigen acquired from intestinal epithelial cells.
Topics: Animals; Antigens; CD8 Antigens; CD8-Positive T-Lymphocytes; Cell Movement; Cell Proliferation; Cells, Cultured; Cross-Priming; Dendritic Cells; Imidazoles; Interferon-gamma; Intestinal Mucosa; Lymph; Lymphocyte Activation; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Ovalbumin; Toll-Like Receptor 7 | 2015 |
Caspase-1 is required for maintenance of marginal zone B cells in pristane-induced lupus.
Topics: Animals; Antibodies, Antinuclear; B-Lymphocytes; Caspase 1; Cells, Cultured; Disease Models, Animal; Ficoll; Genetic Predisposition to Disease; Imidazoles; Immunization; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; Mice, Knockout; Nitrophenols; Ovalbumin; Phenotype; Phenylacetates; Spleen; T-Lymphocytes; Terpenes; Time Factors | 2016 |
Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies; Antibody Formation; beta-Galactosidase; Chitosan; Cytokines; Female; Hemocyanins; Imidazoles; Immunity, Mucosal; Immunization; Immunoglobulin A; Immunoglobulin G; Inflammation; Injections, Intramuscular; Lipopeptides; Macaca mulatta; Mucous Membrane; Ovalbumin; Poly I-C; Thymic Stromal Lymphopoietin | 2015 |
[Resiquimod (R848) has more stronger immune adjuvantivity than other tested TLR agonists].
Topics: Adjuvants, Immunologic; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Dendritic Cells; Imidazoles; Interleukin-12; Killer Cells, Natural; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Ovalbumin; Toll-Like Receptors | 2017 |
The effects of resiquimod in an ovalbumin-induced allergic rhinitis model.
Topics: Animals; Anti-Allergic Agents; Antigens; Cytokines; Disease Models, Animal; Female; Hepatitis A Virus Cellular Receptor 1; Hepatitis A Virus Cellular Receptor 2; Imidazoles; Mice, Inbred BALB C; Nasal Mucosa; Ovalbumin; Rhinitis, Allergic; Spleen | 2018 |
Delivering all in one: Antigen-nanocapsule loaded with dual adjuvant yields superadditive effects by DC-directed T cell stimulation.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Pharmaceutic; Animals; Antigens; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line; Cell Proliferation; Cell Survival; Cytokines; Dendritic Cells; Dextrans; Humans; Imidazoles; Mice, Inbred C57BL; Mice, Transgenic; Nanocapsules; Ovalbumin; Spermine; T-Lymphocytes | 2018 |
Injectable, Ribbon-Like Microconfetti Biopolymer Platform for Vaccine Applications.
Topics: Adjuvants, Immunologic; Animals; Biopolymers; Cytokines; Dendritic Cells; Dextrans; Drug Carriers; Imidazoles; Immunity, Humoral; Mice; Mice, Inbred C57BL; Ovalbumin; Particle Size; RAW 264.7 Cells; Vaccines, Synthetic | 2020 |